SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-003948
Filing Date
2024-02-13
Accepted
2024-02-13 17:24:19
Documents
16
Period of Report
2024-02-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbla20240213_8k.htm   iXBRL 8-K 27375
2 EXHIBIT 10.1 ex_625839.htm EX-10.1 9075
  Complete submission text file 0001437749-24-003948.txt   172208

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pbla-20240207.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20240207_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20240207_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20240207_pre.xml EX-101.PRE 11585
17 EXTRACTED XBRL INSTANCE DOCUMENT pbla20240213_8k_htm.xml XML 2828
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39468 | Film No.: 24630155
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)